Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients.

Microbiology spectrum - 3 Sept 2024

Fahnøe Ulrik, Madsen Lone Wulff, Christensen Peer Brehm, Sølund Christina Søhoel, Mollerup Sarah, Pinholt Mette, Weis Nina, Øvrehus Anne, Bukh Jens

Abstract excerpt

Coinfections with human pegivirus 1 (HPgV-1) are common in chronic hepatitis C virus (HCV) patients. However, little is known about whether HPgV-1 is affected by direct-acting antivirals during HCV treatment. Metagenomic analysis and reverse transcriptase-quantitative PCR (RT-qPCR) were performed on RNA from the plasma of 88 selected chronic HCV patients undergoing medical treatment. Twenty (23%) of these HCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoisobutyric Acids
Share to Benzimidazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Flaviviridae Infections

Share to Metagenomics

Share to Pyrrolidines

Share to Quinoxalines

Share to Sofosbuvir

Source

Open in PubMed Open full text

Identifiers

PMID: 39051781
DOI: 10.1128/spectrum.00641-24
PMCID: PMC11370240

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients.PMID 39051781Read ↗

Presence of Human Hepegivirus-1 in a Cohort of People Who Inject DrugsSemantic proximity Read ↗

Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-InfectionSemantic proximity Read ↗

The Second Human Pegivirus, a Non-Pathogenic RNA Virus with Low Prevalence and Minimal Genetic Diversity.Semantic proximity Read ↗

Whole-genome sequencing of human Pegivirus variant from an Egyptian patient co-infected with hepatitis C virus: a case report.Semantic proximity Read ↗

Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCRSemantic proximity Read ↗

Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysis.Semantic proximity Read ↗

Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis.Semantic proximity Read ↗

High HPgV replication is associated with improved surrogate markers of HIV progression.Semantic proximity Read ↗

Viral Co-infection in COVID-19: Prevalence and Clinical Associations of Human PegivirusSemantic proximity Read ↗

Hepatitis C and Human Pegivirus Coinfection in Patients with Chronic Hepatitis C from the Brazilian Amazon Region: Prevalence, Genotypes and Clinical Data.Semantic proximity Read ↗

Prevalence and potential impact of human pegivirus-1 on HIV-1 disease progression among Indian PLHIV.Semantic proximity Read ↗

Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and PegivirusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.